Upregulation of the OXPHOS complex and subsequent activation of TGFβ-SMAD and MAPK (e.g., JNK, ERK, P38) signalling pathways facilitate the EMT process of breast cancer cells. This evidence concerns the gene TGFB1 and breast carcinoma.